Healthcare / Health Information ServicesLSE
$37.00
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 19%
FCF escenarios
weak_data · normalized FCF $-3.1M · quality 51.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
13/100
F
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$17M
P/E
N/A
•EV/EBITDA
N/A
•ROE
-55.9%
↓Gross Margin
74.5%
↑Debt/Equity
0.29
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-9.3%
FCF CAGR
-64.5%
FCF margin
0.7%
FCF / Net income
-0.04x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $9.4M · net income $-1.7M · FCF $66000.0
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $9.4M | $9.4M | $10.3M | $13.5M | $12.6M |
| Net Income | $-1.7M | $-1.7M | $-1.8M | $-3.5M | $-409000.00 |
| EBITDA | $-662000.00 | $-662000.00 | $-542000.00 | $-2.6M | $-530000.00 |
| EPS | — | — | -0.05 | -0.10 | -0.01 |
| Gross Margin | 74.5% | 74.5% | 77.5% | 79.9% | 73.9% |
| Operating Margin | -13.2% | -13.2% | -10.1% | -13.7% | -1.1% |
| Net Margin | -17.8% | -17.8% | -17.3% | -26.0% | -3.2% |
| Balance Sheet | |||||
| Debt/Equity | 0.29 | 0.29 | 0.57 | 2.00 | 0.19 |
| Current Ratio | 0.40 | 0.40 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $66000.00 | $66000.00 | $-3.1M | $-5.0M | $1.5M |
| Returns | |||||
| ROE | -55.9% | -55.9% | -53.1% | -273.4% | -430.5% |
| Valuation | |||||
| P/B | 575.33 | 575.33 | 430.99 | 1415.70 | 36759.44 |
| Growth & Yield | |||||
| Revenue Growth | -9.1% | -9.1% | -23.5% | 7.2% | — |
| EPS Growth | — | — | 54.4% | -676.9% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-5.1%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.05 → n/d
Residual
-5.1%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.